Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Principe

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Antibiotics (Basel, Switzerland)|August 14, 2020
Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo StudiesRoberta Maria Antonello, Luigi Principe, Alberto Enrico Maraolo, et al.
Frontiers in Public Health|April 30, 2026
Correction: Integrating artificial intelligence with genome sequencing against antimicrobial resistance: a narrative reviewGiovanni Scaglione, Nicolò Mastroianni, Alberto Rizzo, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2022
A Two Amino Acid Duplication, L167E168, in the Ω-Loop Drastically Decreases Carbapenemase Activity of KPC-53, a Natural Class A β-LactamaseAlessandra Piccirilli, Sabrina Cherubini, Giuseppe Celenza, et al.
Antibiotics (Basel, Switzerland)|June 27, 2024
Synergistic Activity of Temocillin and Fosfomycin Combination against KPC-Producing <i>Klebsiella pneumoniae</i> Clinical IsolatesVenera Costantino, Luigi Principe, Jai Mehat, et al.
Antibiotics (Basel, Switzerland)|December 23, 2023
Intravenous Fosfomycin for Systemic Multidrug-Resistant <i>Pseudomonas aeruginosa</i> InfectionsGiuseppe Pipitone, Stefano Di Bella, Alberto Enrico Maraolo, et al.
Journal of Clinical Microbiology|June 13, 2014
Epidemic diffusion of OXA-23-producing Acinetobacter baumannii isolates in Italy: results of the first cross-sectional countrywide surveyLuigi Principe, Aurora Piazza, Tommaso Giani, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
<i>Candida lipolytica</i> Bloodstream Infection in an Adult Patient with COVID-19 and Alcohol Use Disorder: A Unique Case and a Systematic Review of the LiteratureOmar Simonetti, Verena Zerbato, Sara Sincovich, et al.
Antibiotics (Basel, Switzerland)|December 23, 2023
Identification of IncA Plasmid, Harboring <i>bla</i><sub>VIM-1</sub> Gene, in <i>S. enterica</i> Goldcoast ST358 and <i>C. freundii</i> ST62 Isolated in a Hospitalized PatientAlessandra Piccirilli, Sascia Di Marcantonio, Venera Costantino, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|May 5, 2020
Zinc Chelators as Carbapenem Adjuvants for Metallo-β-Lactamase-Producing Bacteria: <i>In Vitro</i> and <i>In Vivo</i> EvaluationLuigi Principe, Graziella Vecchio, Gerard Sheehan, et al.
Infection and Drug Resistance|March 23, 2018
Multicenter prospective study on the prevalence of colistin resistance in <i>Escherichia coli</i>: relevance of <i>mcr-1</i>-positive clinical isolates in Lombardy, Northern ItalyLuigi Principe, Aurora Piazza, Carola Mauri, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Antibiotics (Basel, Switzerland)|August 14, 2020
Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo StudiesRoberta Maria Antonello, Luigi Principe, Alberto Enrico Maraolo, et al.
Frontiers in Public Health|April 30, 2026
Correction: Integrating artificial intelligence with genome sequencing against antimicrobial resistance: a narrative reviewGiovanni Scaglione, Nicolò Mastroianni, Alberto Rizzo, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2022
A Two Amino Acid Duplication, L167E168, in the Ω-Loop Drastically Decreases Carbapenemase Activity of KPC-53, a Natural Class A β-LactamaseAlessandra Piccirilli, Sabrina Cherubini, Giuseppe Celenza, et al.
Antibiotics (Basel, Switzerland)|June 27, 2024
Synergistic Activity of Temocillin and Fosfomycin Combination against KPC-Producing <i>Klebsiella pneumoniae</i> Clinical IsolatesVenera Costantino, Luigi Principe, Jai Mehat, et al.
Antibiotics (Basel, Switzerland)|December 23, 2023
Intravenous Fosfomycin for Systemic Multidrug-Resistant <i>Pseudomonas aeruginosa</i> InfectionsGiuseppe Pipitone, Stefano Di Bella, Alberto Enrico Maraolo, et al.
Journal of Clinical Microbiology|June 13, 2014
Epidemic diffusion of OXA-23-producing Acinetobacter baumannii isolates in Italy: results of the first cross-sectional countrywide surveyLuigi Principe, Aurora Piazza, Tommaso Giani, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
<i>Candida lipolytica</i> Bloodstream Infection in an Adult Patient with COVID-19 and Alcohol Use Disorder: A Unique Case and a Systematic Review of the LiteratureOmar Simonetti, Verena Zerbato, Sara Sincovich, et al.
Antibiotics (Basel, Switzerland)|December 23, 2023
Identification of IncA Plasmid, Harboring <i>bla</i><sub>VIM-1</sub> Gene, in <i>S. enterica</i> Goldcoast ST358 and <i>C. freundii</i> ST62 Isolated in a Hospitalized PatientAlessandra Piccirilli, Sascia Di Marcantonio, Venera Costantino, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|May 5, 2020
Zinc Chelators as Carbapenem Adjuvants for Metallo-β-Lactamase-Producing Bacteria: <i>In Vitro</i> and <i>In Vivo</i> EvaluationLuigi Principe, Graziella Vecchio, Gerard Sheehan, et al.
Infection and Drug Resistance|March 23, 2018
Multicenter prospective study on the prevalence of colistin resistance in <i>Escherichia coli</i>: relevance of <i>mcr-1</i>-positive clinical isolates in Lombardy, Northern ItalyLuigi Principe, Aurora Piazza, Carola Mauri, et al.
Pageof 7